Compare, Analyse Novartis with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TEVA PHARMA (Israel) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   TEVA PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-19
TEVA PHARMA
Dec-13
NOVARTIS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs9803,133-   
Low Rs6002,722-   
Sales per share (Unadj.) Rs198.71,798.1-  
Earnings per share (Unadj.) Rs21.0112.3-  
Cash flow per share (Unadj.) Rs22.3257.7-  
Dividends per share (Unadj.) Rs10.0098.33-  
Dividend yield (eoy) %1.33.4 37.7%  
Book value per share (Unadj.) Rs307.51,997.3-  
Shares outstanding (eoy) m24.69848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.6 244.2%   
Avg P/E ratio x37.726.1 144.6%  
P/CF ratio (eoy) x35.511.4 312.5%  
Price / Book Value ratio x2.61.5 175.3%  
Dividend payout %47.787.5 54.5%   
Avg Mkt Cap Rs m19,5082,482,384 0.8%   
No. of employees `0000.644.9 1.3%   
Total wages/salary Rs m1,1710-   
Avg. sales/employee Rs Th8,445.433,925.2 24.9%   
Avg. wages/employee Rs Th2,015.70-   
Avg. net profit/employee Rs Th891.02,119.3 42.0%   
INCOME DATA
Net Sales Rs m4,9071,524,769 0.3%  
Other income Rs m7830-   
Total revenues Rs m5,6891,524,769 0.4%   
Gross profit Rs m123417,559 0.0%  
Depreciation Rs m32123,249 0.0%   
Interest Rs m1629,949 0.1%   
Profit before tax Rs m858264,361 0.3%   
Minority Interest Rs m01,201 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-173,539 0.0%   
Tax Rs m340-3,228 -10.5%   
Profit after tax Rs m51895,251 0.5%  
Gross profit margin %2.527.4 9.1%  
Effective tax rate %39.6-1.2 -3,246.9%   
Net profit margin %10.66.2 168.9%  
BALANCE SHEET DATA
Current assets Rs m8,0551,029,823 0.8%   
Current liabilities Rs m1,850898,093 0.2%   
Net working cap to sales %126.48.6 1,463.6%  
Current ratio x4.41.1 379.7%  
Inventory Days Days4591 49.6%  
Debtors Days Days3496 35.4%  
Net fixed assets Rs m150498,023 0.0%   
Share capital Rs m1233,753 3.3%   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,5921,693,729 0.4%   
Long term debt Rs m0779,648 0.0%   
Total assets Rs m9,8243,484,585 0.3%  
Interest coverage x54.99.8 559.1%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 114.1%   
Return on assets %5.43.6 151.2%  
Return on equity %6.85.6 121.3%  
Return on capital %11.54.9 233.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,943242,969 -0.8%  
From Investments Rs m2,742-86,094 -3.2%  
From Financial Activity Rs m-298-291,458 0.1%  
Net Cashflow Rs m501-134,583 -0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.06 Rs / USD

Compare NOVARTIS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare NOVARTIS With: TTK HEALTHCARE  PFIZER  J.B.CHEMICALS  STERLING BIOTECH  WYETH LTD  



Today's Market

Sensex Opens Higher; Healthcare Stocks Lead(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2% while the Hang Seng is down 0.8%.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Elon Musk Gives Us a Trading Opportunity (Fast Profits Daily)

Jul 28, 2020

Elon Musk made a statement recently which I believe, gives us a fast profit trading opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NOVARTIS SHARE PRICE


Aug 10, 2020 10:57 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS 5-YR ANALYSIS

COMPARE NOVARTIS WITH

FEATURED VIDEOS

Can You Win a Stock Market Championship Using My Penny Stock Strategy? Let's Find Out

How to Use Price Action to Find High Conviction Trading Ideas

Why This Attractive 'Silver' Stock With 9% Dividends Is Not a Buy

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets

More Featured Videos

MARKET STATS